Follow
David A. Power, MD
Title
Cited by
Cited by
Year
Investigating the effects of ego depletion on physical exercise routines of athletes
DC Dorris, DA Power, E Kenefick
Psychology of Sport and Exercise 13 (2), 118-125, 2012
1842012
Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review
D Sternheim, DA Power, R Samtani, A Kini, V Fuster, S Sharma
Journal of the American College of Cardiology 78 (22), 2196-2212, 2021
1032021
Radial versus femoral access for coronary interventions: an updated systematic review and meta‐analysis of randomized trials
M Chiarito, D Cao, J Nicolas, A Roumeliotis, D Power, R Chandiramani, ...
Catheterization and Cardiovascular Interventions 97 (7), 1387-1396, 2021
662021
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: a post hoc analysis from the BRAVO‐3 randomized trial
D Power, U Schäfer, P Guedeney, BE Claessen, S Sartori, S Sorrentino, ...
Catheterization and Cardiovascular Interventions 93 (7), 1374-1381, 2019
422019
A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week
AC Lai, SW Bienstock, R Sharma, K Skorecki, F Beerkens, R Samtani, ...
Journal of the American College of Cardiology 77 (11), 1470-1479, 2021
382021
Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review
DA Power, J Lampert, A Camaj, SW Bienstock, N Kocovic, A Bayes-Genis, ...
Journal of the American College of Cardiology 79 (12), 1199-1211, 2022
232022
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis
V Razuk, M Chiarito, D Cao, J Nicolas, CA Pivato, A Camaj, D Power, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (6), 557-567, 2022
212022
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial
R Goel, D Power, D Tchetche, R Chandiramani, P Guedeney, ...
International journal of cardiology 297, 22-29, 2019
152019
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction
J Thromb Thrombolysis https://doi.org/10.1007/s11239-021-02534-z, 2021
13*2021
Effect of stent diameter in women undergoing percutaneous coronary intervention with early-and new-generation drug-eluting stents: From the WIN-DES collaboration
A Camaj, G Giustino, BE Claessen, U Baber, DA Power, S Sartori, ...
International journal of cardiology 287, 59-61, 2019
102019
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
The American Journal of Cardiology, 2019
102019
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: insights from the WIN‐TAVI registry
J Nicolas, BE Claessen, D Cao, S Sartori, U Baber, D Power, M Chiarito, ...
Catheterization and Cardiovascular Interventions 97 (5), E704-E715, 2021
92021
Optimal duration of dual antiplatelet therapy after PCI: integrating procedural complexity, bleeding risk and the acuteness of clinical presentation
H Chen, D Power, G Giustino
Expert Review of Cardiovascular Therapy 16 (10), 735-748, 2018
92018
Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: a meta regression‐based analysis
Y Sattar, A Abdul Razzack, R Kompella, N Alhajri, J Arshad, W Ullah, ...
Catheterization and Cardiovascular Interventions 99 (1), E1-E11, 2022
82022
Prevalence and impact of high bleeding risk in patients undergoing left main artery disease PCI
M Chiarito, A Kini, A Roumeliotis, D Cao, D Power, S Sartori, A Reisman, ...
Cardiovascular Interventions 14 (22), 2447-2457, 2021
62021
Effect of elevated C-reactive protein on outcomes after complex percutaneous coronary intervention for angina pectoris
A Camaj, G Giustino, N Kocovic, D Cao, BE Claessen, S Sartori, Z Zhang, ...
The American Journal of Cardiology 168, 47-54, 2022
52022
Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO‐3 randomized trial
V Razuk, A Camaj, D Cao, J Nicolas, C Hengstenberg, S Sartori, Z Zhang, ...
Catheterization and Cardiovascular Interventions 98 (6), E870-E880, 2021
52021
Impact Of Target Vessel Choice On Outcomes Following Percutaneous Coronary Intervention In Patients With A Prior Coronary Artery Bypass Graft
KA Beerkens F, Singh R, Cao D, Nicolas J, Razuk V, Jones B, Sartori S ...
Journal of the American College of Cardiology; ACC Scientific Sessions 2021 …, 2021
5*2021
Adjunct Pharmacotherapy After Transcatheter Aortic Valve Replacement: Current Status and Future Directions.
DA Power, P Guedeney, GD Dangas
Interventional Cardiology Clinics 8 (4), 357-371, 2019
52019
Interatrial block association with adverse cardiovascular outcomes in patients without a history of atrial fibrillation
J Lampert, D Power, S Havaldar, U Govindarajulu, I Kawamura, A Maan, ...
Clinical Electrophysiology 9 (8_Part_3), 1804-1815, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–20